Published in Arch Med Sci on October 08, 2012
Biomaterial-mediated strategies targeting vascularization for bone repair. Drug Deliv Transl Res (2016) 0.79
Reiterated Targeting Peptides on the Nanoparticle Surface Significantly Promote Targeted Vascular Endothelial Growth Factor Gene Delivery to Stem Cells. Biomacromolecules (2015) 0.77
Clinical analysis of the rap stress stimulator applied for crus fracture after skeletal external fixation. Arch Med Sci (2015) 0.75
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem (1998) 8.30
Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells (2001) 6.86
Role of collagenous matrices in the adhesion and growth of cells. J Cell Biol (1981) 5.60
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials (2000) 4.42
Self-regulation of growth in three dimensions. J Exp Med (1973) 2.87
VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene (1999) 2.66
Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials (2001) 1.94
Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res (2005) 1.57
Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental "niches" in culture: a two-stage hypothesis for regulation of MSC fate. Sci STKE (2005) 1.54
The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials (2008) 1.27
Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation (1996) 1.26
Mechanism of bone metastasis: the role of osteoprotegerin and of the host-tissue microenvironment-related survival factors. Cancer Lett (2009) 1.22
Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ Res (2001) 1.10
Impact of pore size on the vascularization and osseointegration of ceramic bone substitutes in vivo. J Biomed Mater Res A (2008) 1.08
In vitro biocompatibility assessment of naturally derived and synthetic biomaterials using normal human urothelial cells. J Biomed Mater Res (2001) 1.04
Biomaterials in orthopaedic surgery: effects of different hydroxyapatites and demineralized bone matrix on proliferation rate and bone matrix synthesis by human osteoblasts. Biomaterials (1995) 0.99
Bone tissue engineering evaluation based on rat calvaria stromal cells cultured on modified PLGA scaffolds. Biomaterials (2005) 0.94
Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia. Circulation (1998) 0.92
Skeletal repair in rabbits using a novel biomimetic composite based on adipose-derived stem cells encapsulated in collagen I gel with PLGA-beta-TCP scaffold. J Orthop Res (2010) 0.91
Therapeutic implications of osteoprotegerin. Cancer Cell Int (2009) 0.89
Collagen I gel can facilitate homogenous bone formation of adipose-derived stem cells in PLGA-beta-TCP scaffold. Cells Tissues Organs (2007) 0.88
Bioabsorbable materials for guided bone regeneration prior to implant placement and 7-year follow-up: report of 14 cases. J Periodontol (2001) 0.86
Evaluation of guided bone regeneration in rabbit femur using collagen membranes. Implant Dent (2000) 0.85
Cell-cell interaction promotes rat marrow stromal cell differentiation into endothelial cell via activation of TACE/TNF-alpha signaling. Cell Transplant (2009) 0.84
Effects of clodronate combined with hydroxyapatite on multi-directional differentiation of mesenchymal stromal cells. Arch Med Sci (2010) 0.84
Osteogenetic properties of reimplanted decalcified and undecalcified autologous bone in the rabbit radius. Scand J Plast Reconstr Surg (1982) 0.79
Short and long-term effects of hVEGF-A(165) in Cre-activated transgenic mice. PLoS One (2006) 0.79